Laminin (925-933): Precision Cell Adhesion Peptide for ECM Research

Executive Summary: Laminin (925-933) is a synthetic peptide corresponding to residues 925-933 of the laminin beta 1 chain, supporting high-specificity cell adhesion and migration assays (Laminin (925-933)). This peptide binds the laminin receptor, recapitulating a key functional domain in the extracellular matrix glycoprotein laminin (McGeachan et al., 2025). Laminin (925-933) displays robust activity in promoting HT-1080 and CHO cell attachment at 100–300 µg/mL, and functions as a chemoattractant for B16F10 melanoma cells. It can competitively inhibit chemotactic responses to full-length laminin, confirming its functional relevance in cell migration modulation. APExBIO supplies this peptide (SKU: A1023) with characterized solubility and stability for research uses only.

Biological Rationale

Laminins are heterotrimeric extracellular matrix proteins composed of alpha, beta, and gamma chains. They are major structural components of basement membranes and play essential roles in cell adhesion, migration, differentiation, and signaling (McGeachan et al., 2025). The beta 1 chain, from which Laminin (925-933) is derived, is widely expressed in tissues that produce basement membranes. This domain (residues 925-933; Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg) is implicated in cell attachment, chemotaxis, and receptor binding. Laminin fragments containing this sequence have been shown to replicate key biological activities of full-length laminin, facilitating detailed studies of extracellular matrix signaling and metastasis (Laminin (925-933): A Precision ECM Peptide for Cell Adhes...). This article extends previous coverage by focusing on experimental benchmarks and practical workflow parameters.

Mechanism of Action of Laminin (925-933)

Laminin (925-933) specifically binds the laminin receptor, mimicking a key functional domain of the beta 1 chain. This interaction mediates cell attachment and migration via extracellular matrix signaling pathways. The peptide's competitive inhibition of full-length laminin-induced chemotaxis demonstrates its receptor specificity and functional mimicry. Quantitative assays show that Laminin (925-933) stimulates the attachment of HT-1080 human fibrosarcoma and CHO cells at concentrations between 100–300 µg/mL. As a chemoattractant, it elicits approximately 30% of the maximal response compared to full-length laminin in B16F10 murine melanoma cells. This property enables its use in mechanistic studies of cell adhesion, migration, and metastasis inhibition (McGeachan et al., 2025).

Evidence & Benchmarks

• Laminin (925-933) promotes HT-1080 and CHO cell attachment at 100–300 µg/mL, confirming dose-dependent activity (APExBIO).
• The peptide acts as a chemoattractant for B16F10 murine melanoma cells, eliciting ~30% of maximal chemotactic response relative to full-length laminin (McGeachan et al., 2025).
• Laminin (925-933) competitively inhibits chemotactic responses to full-length laminin, supporting its role as a receptor-binding domain (Laminin (925-933): A Precision ECM Peptide for Cell Adhes...).
• Peptide is a solid, molecular weight 967.06 Da, with solubility ≥15.53 mg/mL in water, ≥17.77 mg/mL in ethanol, and ≥48.35 mg/mL in DMSO; storage at -20°C is recommended (APExBIO).
• Basement membrane proteins like laminin are implicated in synaptic and neuronal health, relevant to neurodegenerative disease models (McGeachan et al., 2025).

Applications, Limits & Misconceptions

Laminin (925-933) is validated for use in cell adhesion, migration, and chemotaxis assays involving HT-1080, CHO, and B16F10 cells. The peptide's defined sequence and robust receptor binding make it ideal for benchmarking cell adhesion and migration studies, as detailed in Laminin (925-933): Mechanistic Precision and Strategic Op.... This article emphasizes the parameterization and assay integration aspects previously underexplored. The peptide is not a substitute for full-length laminin in structural or multi-domain functional studies.

Common Pitfalls or Misconceptions

• Laminin (925-933) does not replicate the full structural or multivalent functions of native laminin heterotrimers.
• It is not suitable for studies requiring matrix polymerization or mechanical stability of basement membranes.
• The peptide's activity may vary outside the recommended concentration range (100–300 µg/mL for cell attachment).
• It is not for diagnostic or medical use; research use only as specified by APExBIO.
• Does not provide signaling cues from non-beta 1 chain laminin domains or non-laminin ECM proteins.

Workflow Integration & Parameters

Laminin (925-933) (SKU: A1023) is supplied as a solid and should be dissolved in water (≥15.53 mg/mL), ethanol (≥17.77 mg/mL), or DMSO (≥48.35 mg/mL) for experimental use. Short-term solutions are recommended for stability; long-term storage at -20°C preserves activity. For cell adhesion assays, coat surfaces with 100–300 µg/mL peptide in suitable buffer. For chemotaxis assays, use concentrations validated for B16F10, HT-1080, or CHO cells. For detailed protocols, users may consult Laminin (925-933): Data-Driven Solutions for Reliable Cel..., which this article extends by specifying comparative benchmarks and troubleshooting advice. APExBIO provides batch-specific documentation to support reproducibility.

Conclusion & Outlook

Laminin (925-933) is a validated synthetic peptide that delivers specific, reproducible results in cell adhesion and migration assays. Its defined mechanism of receptor binding and chemotactic modulation supports advanced research in extracellular matrix signaling, metastasis, and neurodegeneration. As a product of APExBIO, Laminin (925-933) offers researchers a high-specificity tool for dissecting ECM-driven processes. For expanded mechanistic and protocol guidance, see Scenario-Driven Solutions with Laminin (925-933) in Cell-...; this article provides a more granular, evidence-based framework for parameter selection and experimental design. With continued study, this peptide will remain central in bridging ECM research and translational cell biology.